| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00cf135003c69ae281b696d3bc73e0c9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6869 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2012-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab94eee595676180ad8a7171340b08f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215dbb2360a0e2ee6e744ca506871a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_501b25c5730d9fc6bd47ed81b8a004e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57971ac451cdeadb8f48dd15d0070afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3bcc605d02fb441bdedb22a11d174dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08f773bd10a541de69034e6cabe4c5d0 |
| publicationDate |
2019-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3534159-A1 |
| titleOfInvention |
Lipocalin 2 as a biomarker for il-17 inhibitor therapy efficacy |
| abstract |
The present invention provides the use of lipocalin 2 (LCN2) as a biomarker for IL-17 mediated diseases and for monitoring the response of a patient to anti-IL-17 therapy. |
| priorityDate |
2011-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |